LISAvienna: February 2022 - Newsletter available online

Name: _pk_id Used for : Is used to store an unique ID for each user Duration : 13 Months
Name: &nbsp;_pk_ses, _pk_cvar, _pkhsr Used for :&nbsp;Session cookies that store temporary data Duration :&nbsp;30 minutes
Name: mtm_consent Used for : Stores cookie preferences Duration : 30 years

Today we highlight news items from BOKU, breathe ilo, Cebina, Epistome Austria, Eveliqure, Herba Chemosan, hi.health, Hookipa Pharma, myReha, NovoArc, piur imaging, Pregenerate, Ribbon Biolabs, rotable, Scarletred, TAmiRNA, Valneva, VelaLabs, ViruSure and XUND.

In addition, we update you on funding opportunities and events.

Read online: https://mailchi.mp/lisavienna/newsletter-february-28-2022
Subscribe at no cost: https://www.lisavienna.at/newsletter/

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.

LISAvienna: February 2022 - Newsletter available online

MedUni Vienna: Identification of specific immune cells using fluorescence and digital histology in brain tumour operations

vetmeduni Wien: Von der Transkriptomik zur Saisonalität: Die Genexpression im Gehirn zeigt, wie Vögel während ihrer nächtlichen Wanderungen Energie verbrauchen können

a:head secures pre-Series A funding and appoints Margarete Schramboeck and Madeline Lancaster to the Supervisory Board